CTMX
Price
$2.12
Change
+$0.08 (+3.92%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
321.39M
77 days until earnings call
REGN
Price
$596.65
Change
-$7.97 (-1.32%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
65.28B
70 days until earnings call
Interact to see
Advertisement

CTMX vs REGN

Header iconCTMX vs REGN Comparison
Open Charts CTMX vs REGNBanner chart's image
CytomX Therapeutics
Price$2.12
Change+$0.08 (+3.92%)
Volume$17.07K
Capitalization321.39M
Regeneron Pharmaceuticals
Price$596.65
Change-$7.97 (-1.32%)
Volume$12.03K
Capitalization65.28B
CTMX vs REGN Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. REGN commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and REGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CTMX: $2.04 vs. REGN: $604.62)
Brand notoriety: CTMX: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 53% vs. REGN: 90%
Market capitalization -- CTMX: $321.39M vs. REGN: $65.28B
CTMX [@Biotechnology] is valued at $321.39M. REGN’s [@Biotechnology] market capitalization is $65.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while REGN’s TA Score has 5 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 4 bearish.
  • REGN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, REGN is a better buy in the short-term than CTMX.

Price Growth

CTMX (@Biotechnology) experienced а -14.29% price change this week, while REGN (@Biotechnology) price change was +5.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

CTMX is expected to report earnings on Aug 07, 2025.

REGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($65.3B) has a higher market cap than CTMX($321M). REGN has higher P/E ratio than CTMX: REGN (15.37) vs CTMX (4.25). CTMX YTD gains are higher at: 98.058 vs. REGN (-14.886). CTMX has less debt than REGN: CTMX (9.39M) vs REGN (2.71B).
CTMXREGNCTMX / REGN
Capitalization321M65.3B0%
EBITDA26.8MN/A-
Gain YTD98.058-14.886-659%
P/E Ratio4.2515.3728%
Revenue138MN/A-
Total Cash101MN/A-
Total Debt9.39M2.71B0%
FUNDAMENTALS RATINGS
CTMX vs REGN: Fundamental Ratings
CTMX
REGN
OUTLOOK RATING
1..100
197
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
9954
PRICE GROWTH RATING
1..100
3461
P/E GROWTH RATING
1..100
9594
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (3) in the Biotechnology industry is significantly better than the same rating for CTMX (72). This means that REGN’s stock grew significantly faster than CTMX’s over the last 12 months.

REGN's Profit vs Risk Rating (88) in the Biotechnology industry is in the same range as CTMX (100). This means that REGN’s stock grew similarly to CTMX’s over the last 12 months.

REGN's SMR Rating (54) in the Biotechnology industry is somewhat better than the same rating for CTMX (99). This means that REGN’s stock grew somewhat faster than CTMX’s over the last 12 months.

CTMX's Price Growth Rating (34) in the Biotechnology industry is in the same range as REGN (61). This means that CTMX’s stock grew similarly to REGN’s over the last 12 months.

REGN's P/E Growth Rating (94) in the Biotechnology industry is in the same range as CTMX (95). This means that REGN’s stock grew similarly to CTMX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXREGN
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 3 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109678.0800002886.992200
+2.70%
Bitcoin cryptocurrency
GME28.05-0.46
-1.61%
GameStop Corp
SPY582.86-9.99
-1.69%
SPDR® S&P 500® ETF
AAPL202.09-4.77
-2.31%
Apple
TSLA334.62-9.20
-2.68%
Tesla

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with REGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.97%
REGN - CTMX
38%
Loosely correlated
-1.65%
BCAB - CTMX
37%
Loosely correlated
-2.40%
CRNX - CTMX
37%
Loosely correlated
-4.53%
NKTR - CTMX
37%
Loosely correlated
-7.95%
APGE - CTMX
35%
Loosely correlated
-0.40%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with KRYS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-1.65%
KRYS - REGN
45%
Loosely correlated
-3.70%
TECH - REGN
45%
Loosely correlated
-5.79%
ROIV - REGN
43%
Loosely correlated
-1.18%
VRTX - REGN
43%
Loosely correlated
-2.65%
IDYA - REGN
43%
Loosely correlated
-2.45%
More